| Name: |
ADENOSINE (AdenocardR) |
| Classification: |
Antiarrhythmic:
- produces short acting AV block to aid in the diagnosis of supraventricular tachycardias
- may convert PSVT to sinus rhythm when verapamil is not effective or is contraindicated
|
| Dose: |
Bolus Dose:
- 6 mg IV rapid bolus
- may repeat with 12 mg IV bolus every 1-2 minutes to a maximum total dose of 30 mg
- should be given as close to the site, and as quickly as possible
|
| Administration: |
IV Infusion:
- rapidly undiluted as bolus BDC
|
| Adverse Effects: |
- cardiovascular
- sinus bradycardia, sinus arrest, atrial fibrillation, AV block (usually < 1 minute)
- hypotension
- non-cardiovascular
- flushing and dyspnea
- headache, cough, malaise, or nausea usually lasting <1 minute due to very short half life
|
| Drug Interactions: |
- adenosine + aminophylline/theophylline = decreased adenosine effect
- adenosine + digoxin = bradycardias and increased AV blocks
- adenosine + verapamil = bradycardias and increased AV blocks
- adenosine + beta blockers = bradycardias and increased AV blocks
|
| Monitoring Therapy: |
- ECG, rhythm
- blood pressure
|
| CCTC Protocol: |
- Must be administered by a physician in CCTC.
- This drug must be given by rapid BDC bolus.
|
Print
Handheld
Contrast
